It is known that excess amounts of Ski, or any member of its proto-oncoprotein family, causes disruption of the transforming growth factor beta signal transduction pathway, thus causing oncogenic transformation of cells. Previous studies indicate that Ski is a relatively unstable protein whose expression levels can be regulated by ubiquitin-mediated proteolysis. Here, we investigate the mechanism by which the stability of Ski is regulated. We show that the steady-state levels of Ski protein are controlled post-translationally by cell cycle-dependent proteolysis, wherein Ski is degraded during the interphase of the cell cycle but is relatively stable during mitosis. Furthermore, we demonstrate that the ubiquitin-conjugating enzyme Cdc34 mediates cell cycle-dependent Ski degradation both in vitro and in vivo. Overexpression of dominant-negative Cdc34 stabilizes Ski and enhances its ability to antagonize TGF-b signaling. Our data suggest that regulated proteolysis of Ski is one of the key mechanisms that control the threshold levels of this proto-oncoprotein, and thus prevents epithelial cells from becoming TGF-b resistant.
Introduction
Members of the Ski/ski-related novel gene (Sno) gene family play important roles in regulating cell proliferation and differentiation Luo, 2003; Medrano, 2003) . Aberrant expression of these genes can cause oncogenic transformation and perturb cell cycle progression. The founding member of this gene family, v-ski, was discovered as the oncogene present in the avian Sloan-Kettering viruses formed during the passage of a transformation-defective avian leukosis virus Stavnezer et al., 1986) . The v-ski oncogene causes morphological transformation and anchorage-independent growth of chicken embryo fibroblasts (Colmenares and Stavnezer, 1989; Colmenares et al., 1991) . v-ski arises from a deletion of the carboxyl-terminal sequence of the cellular homolog cski. snoN (ski-related novel gene) is a member of the ski gene family and shares a large region of homology in the amino-terminus with ski as well as a highly conserved carboxyl-terminal domain featuring imperfect tandem repeats and an a-helical leucine zipper motif (Nagase et al., 1993; Heyman and Stavnezer, 1994; Zheng et al., 1997) . This carboxyl-terminal domain has been shown to be responsible for homo-and hetero-oligomerization of various family members of Ski proto-oncoproteins (Zheng et al., 1997; Cohen et al., 1999) . Other forms of Sno-related genes are generated by alternative splicing mechanisms (Pearson-White, 1993; Pearson-White and Crittenden, 1997) .
Several lines of evidence suggest that the levels of Ski and SnoN expression are crucial for biological activities (Colmenares et al., 1991; Boyer et al., 1993) . Manipulating the levels of Ski and SnoN expression in animals revealed the critical roles this gene family plays during animal development. Transgenic mice overexpressing ski exhibit increased muscle mass due to hypertrophy of type II fast muscle fibers (Sutrave et al., 1990b; Sutrave et al., 2000) . In contrast, mice lacking the ski protooncogene due to a genetic 'knockout' have multiple defects in the central nervous system and in skeletal muscle development as a result of defects in proliferation of precursor cells for these tissues (Berk et al., 1997) . Mice lacking SnoN died at an early stage of embryogenesis and exhibited no blastocyst formation (Shinagawa et al., 2000) . Unexpectedly, SnoN þ /À heterozygous mice are hypersensitive to chemical carcinogens and develop spontaneous lymphomas at much higher frequencies than do wild-type SnoN þ / þ mice. This result suggests that SnoN may act as a tumor suppressor (rather than an oncogene) in some types of cells. From these results it appears that hyperexpression of SnoN can transform fibroblasts, while hypoexpression of SnoN makes cells susceptible to transformation. Thus, the levels of expression dictate the phenotypes in the animal.
Several studies indicate that the levels of c-ski are significantly higher in human tumor cell lines derived from neuroblastoma, melanoma and prostate cancers (Nomura et al., 1989; Fumagalli et al., 1993; Reed et al., 2001; Zhang et al., 2003) . These studies support the notion that the transforming activity of Ski may be attributable to variable levels of expression and may provide a basis for human tumorigenesis.
TGF-b is a negative growth factor for many epithelial cells. The loss of TGF-b growth inhibition is a hallmark that typifies many types of human tumors (Hanahan and Weinberg, 2000) . It has recently been shown that overexpression of Ski antagonizes the normal growth inhibitory response to TGF-b and enables cells to grow in the presence of TGF-b (Akiyoshi et al., 1999; Luo et al., 1999; Sun et al., 1999a; Xu et al., 2000) . Ski affects this pathway through a direct interaction with the Smad signaling complexes upon ligand stimulation. The presence of Ski in the Smad complexes alters the normal transcriptional response elicited by TGF-b. The presence of Ski in the Smad signaling complex could alter its subcellular localization (Reed et al., 2001) , distort the proper interaction between Smad3 and Smad4 (Wu et al., 2002) or impact R-Smad phosphorylation (Prunier et al., 2003) . Furthermore, TGF-b also stimulates rapid degradation of Ski and SnoN in a ubiquitin-dependent manner Sun et al., 1999b; Stroschein et al., 2001; Wan et al., 2001 ). This response is likely to be important for removing these two negative regulators of TGF-b signaling and thereby establishing growth arrest for epithelial cells in the presence of TGFb. Overexpression of Ski results in the incomplete removal of this proto-oncoprotein and abrogation of TGF-b signaling. Therefore, in normal epithelial cells, the levels of Ski have to be tightly regulated to maintain a normal response to TGF-b.
Here, we investigate whether regulated protein degradation is involved in controlling the steady-state levels of Ski. We found that Ski protein levels fluctuate during cell cycle progression. The steady-state level of Ski is low during the G1 and S phases of the cell cycle, but accumulates during mitosis. Using a cell-free protein degradation system, we observed that Ski is selectively degraded in interphase cell extracts but not in mitotic cell extracts. Cell cycle-dependent degradation of Ski requires the activity of ubiquitin-conjugating enzyme Cdc34. We show that the addition of a recombinant dominant-negative form of Cdc34 or addition of a neutralizing antibody against Cdc34 to the interphase cell extracts inhibits Ski degradation. Furthermore, we show that while overexpression of the wild-type Cdc34 enhances Ski degradation in cultured cells, dominantnegative Cdc34 can stabilize Ski in vivo. Our data suggest that a Cdc34-dependent protein degradation pathway controls the steady-state level of Ski during the G1/S phase of the cell cycle and ensures the proper cellular response to TGF-b in epithelial cells.
Results
Cell cycle-dependent regulation of the steady state level of Ski in vivo To determine whether the Ski protein is regulated by the cell cycle progression in vivo, we measured the steadystate level of Ski in synchronized HeLa cells. Two properties of HeLa cells make them desirable for this study. First, HeLa S3 cells can be efficiently synchronized using a double thymidine block to arrest them at early S phase of the cell cycle. Following release from thymidine, cells synchronously move through G2, M and G1 phases of the cell cycle. This cell cycle progression can be monitored by FACS analysis as shown in Figure 1a . Second, the anti-Ski monoclonal antibody recognizes endogenous human Ski efficiently, making human lines advantageous. Equal amounts of cell extracts obtained from different stages of the cell cycle were prepared and the levels of Ski were determined by immunoblotting with an anti-Ski monoclonal antibody. As a loading control, Erk2 levels were determined by immunoblotting with an anti-Erk2 antibody ( Figure 1b) . As shown in Figure 1b , the steady-state levels of Ski vary significantly during cell cycle progression, with the highest level observed during mitosis and a rapid decline observed after mitosis. The levels of Ski remain low until the onset of mitosis, suggesting that the stability of Ski is also likely regulated by cell cycle progression in vivo (Figure 1c) .
The difference in the observed levels of Ski could be due to either a difference in the transcription rate of the gene during different phases of the cell cycle or from post-transcriptional control mechanisms. To determine whether variations in Ski levels during cell cycle progression are promoter specific and therefore due to differential transcription rates, we next asked whether recombinant Ski protein could also be subjected to cell cycle regulation when ectopically expressed in mink lung epithelial cells. Mink lung cells are highly sensitive to TGF-b and overexpression of Ski in this cell line disrupts TGF-b signaling. HA-tagged Ski was stably expressed in mink lung epithelial cells using a recombinant retrovirus. Cells were subsequently synchronized by density-induced contact inhibition (Laiho et al., 1990) . After a 2-week growth arrest, cells were split into the fresh growing media and released synchronously (Figure 1d ). Equal amounts of cell extracts obtained from different stages of the cell cycle were prepared and the levels of HA-Ski were determined by immunoblotting with an anti-HA antibody. As a control for gel loading, we also probed the same blot with an antitubulin antibody. As shown in Figures 1e and 1f , the level of HA-Ski is low during G1/S phase of the cell cycle and peaks during mitosis. Since the levels of both endogenous and recombinant Ski fluctuate during cell cycle progression, these data suggest that regulated proteolysis rather than transcription rate may be responsible for the fluctuating steady-state levels of Ski.
Cell cycle-dependent degradation of the Ski family of proto-oncoproteins in vitro To further explore whether regulated proteolysis is important for controlling the steady-state level of Ski, we investigated the stability of Ski and SnoN in Xenopus egg extracts prepared from the interphase or Cell cycle-dependent degradation of Ski M Macdonald et al mitotic phase of the cell cycle. Frog extracts can be biochemically synchronized and provide a system amenable to cell cycle-dependent protein degradation analysis. We observed that Ski was rapidly degraded in interphase extracts. In contrast, Ski was degraded at a slower rate and underwent a mobility shift in mitotic cell extracts (Figure 2a and 2b) . Preliminary experiments suggest that the mobility shift is caused by phosphorylation (Macdonald and Liu, unpublished observations). At least two possibilities could account for the slower degradation rate of Ski in mitotic extracts. Either the conformation of Ski during mitosis is different or the enzymes that ubiquitinate Ski in the interphase part of the cell cycle are inactive during mitosis. In contrast, Ski-related protein SnoN showed the opposite behavior, in which degradation of SnoN only occurred in mitotic cell extracts, but not in interphase extracts ( Figure 2a) . As a control, in vitro translated Smad3 and green fluorescence protein (GFP) were incubated with interphase and mitotic cell extracts. The levels of both proteins remained unchanged throughout the incubation period (Figure 2a ). These data indicate that the stability of Ski and SnoN are differentially regulated during cell cycle progression. Since destabilization of Ski occurs primarily in the interphase of somatic cells and interphase cell extracts, we chose to focus on investigating the mechanism and consequences of Ski degradation in the interphase portion of the cell cycle. It has been previously demonstrated that cell cycledependent degradation of SnoN is mediated by the APC Wan et al., 2001) . Both Ski and SnoN contain conserved destruction boxes (RXXLXXXXN) at their N-termini ( Figure 2c ). Mutation of the D-box in SnoN abolished cell cycledependent degradation of SnoN, indicating that the D-box is critical for SnoN destruction Wan et al., 2001) . To determine whether the Dbox of Ski is also important for Ski degradation, we mutated it by deletion and point mutations of the conserved amino-acid residues. As shown in Figure 2d , none of the mutations affects the Ski degradation in cell extracts. However, cell cycle-dependent degradation of Ski is likely mediated through the ubiquitin-proteasome pathway, since adding the proteasome inhibitor MG132 stabilizes Ski in cell extracts (data not shown). These data suggest the conserved D-box motif in Ski is neither necessary nor sufficient for Ski degradation and cell cycle-dependent degradation of Ski and SnoN occurs through different pathways.
Transcriptional repression of TGF-b-dependent genes by variable levels of Ski
We have demonstrated that overexpression of Ski using a transient transfection assay represses transcriptional activation of a TGF-b-dependent reporter gene (Sun et al., 1999a) . To determine whether variations in Ski expression levels affect cellular responses to extracellular stimuli, we constructed two stable cell lines expressing different levels of Ski. As shown in Figure 3a , the wild-type Ski was inserted into a bicistronic retroviral expression vector (Liu et al., 2000) . A cell surface marker gene mCD2 whose expression is controlled by an internal ribosomal entry site (IRES) was placed downstream of Ski. Recombinant retrovirus produced by this vector was used to infect mink lung epithelial cell line PE25, in which a luciferase reporter gene driven by a minimal promoter from a TGF-b-inducible gene PAI-1 was stably integrated into the genome (Hua et al., 1998 ). By sorting a defined level of cell surface expression of mCD2, we were able to obtain stable cell lines expressing two distinct levels of Ski (Figure 3a and b) . To determine whether there is a correlation between the expression levels of Ski and transcriptional repression of the PAI-1 reporter gene, equal numbers of the control, low Ski and high Ski expression cells were incubated with or without 100 pM TGF-b for 24 h prior to measuring luciferase activity. After stimulation by TGF-b for 24 h, there is a more than sevenfold increase in reporter gene expression in control cells (Figure 3c ). Elevated levels of Ski are inversely correlated with the 
Degradation of Ski is mediated by Cdc34 in vitro
To dissect the proteolytic pathway required for the degradation of Ski biochemically, we set out to identify the potential ubiquitin-conjugating enzyme (E2) involved. Since degradation of Ski occurs only in G1/ S phase of the cell cycle, we tested several known E2s that have been shown to mediate cell cycle-dependent degradation of a number of cell cycle regulatory proteins. Mutations of the conserved cysteine residue in the active site of ubiquitin-conjugating enzymes have been shown to inhibit ubiquitination reactions in a dominant-negative manner. We have purified several recombinant dominant-negative E2 proteins, including Ubc5aDN, Ubc10DN and Cdc34DN. The effects of these E2 proteins on the stability of Ski in the interphase cell extracts described above were tested.
35
S-labeled Ski was incubated with 5 mM of each E2 protein for the indicated time.
S-labeled GFP was also added to the extracts simultaneously. Recombinant GFP is very stable in these extracts and served as an internal control for gel loading and quantitation of Ski degradation. As shown in Figure 4 , among all three E2 proteins tested in this experiment, only dominant-negative Cdc34 can inhibit Ski degradation. Addition of other E2s has minimal effect on Ski degradation in vitro (Figure 4) .
To further test whether Cdc34 is required for the degradation of Ski, we first tried to deplete Cdc34 from the cell extracts and test whether removal of Cdc34 affects Ski degradation. Immunoblotting of the interphase cell extracts showed that the Cdc34 antibody recognized a single protein band similar in size to the recombinant Cdc34 (recombinant Cdc34 contains a six histidine residue tag at its N-terminus) (Figure 5a ). Partial depletion of Cdc34 using this monoclonal antibody against Cdc34 resulted in only a partial inhibition of Ski degradation (data not shown). However, when the Cdc34 antibody was added directly to the interphase cell extracts, Ski degradation was effectively inhibited (Figures 5b and c) . To determine whether the recombinant Cdc34 could negate the antibody effect on Ski degradation (Figure 5d ), various amounts of recombinant Cdc34 were added to the cell extracts along with the antibody. In the presence of 2 mM of recombinant Cdc34, Ski degradation was effectively restored while adding back less than 0.2 mM of Cdc34 failed to restore the activity (Figures 5b and c) . As a control, we added a 6XHis-tagged recombinant HDAC4N protein (corresponding to amino acids 1-204 of HDAC) to the interphase extracts. The latter does not negate the effect of the anti-Cdc34 antibody (Figure 5e ). The purity of the recombinant proteins was analysed by Coomassie Blue staining and addition of recombinant HDAC4N alone does not affect Ski degradation (Figures 5d and e) . Neither addition of a normal mouse serum (Figure 5e ) nor a control antibody against N-ras (data not shown) had any effect on Ski degradation, suggesting the effect of this antibody is 
Regulation of Ski degradation by Cdc34 in vivo
To determine whether Cdc34 also regulates Ski degradation in vivo, we cotransfected wild-type Cdc34 or dominant-negative Cdc34DN with HA-Ski into 293T cells. As shown in Figure 6 , coexpression of HA-Ski with wild-type Cdc34 resulted in a dramatic decrease of Ski protein, while coexpression of dominant-negative Cdc34DN stabilized Ski (Figure 6, lanes 1-3) . The effect of wild-type Cdc34 on Ski degradation could be partially reversed by treatment with MG132 ( Figure 6a , lanes 4-6), indicating that Ski is degraded by the ubiquitin-proteasome machinery via a Cdc34-dependent pathway in intact cultured cells.
In Figure 1 , we showed that the steady-state level of Ski is low in G1/S phase of the cell cycle and peaks during mitosis. If Cdc34 regulates Ski degradation during cell cycle progression, we would expect such regulation would be disrupted by overexpression of dominant-negative Cdc34. To test this hypothesis, we took mink lung epithelial cells that expressed HA-Ski stably and infected them with recombinant retrovirus to stably express either the wild-type or the dominantnegative Cdc34 mutant. Cdc34 and Cdc34DN were stably expressed using a bicistronic retroviral vector, pMX-IRES-GFP. Ectopic expression of Cdc34 and Cdc34DN was confirmed by Western blot analysis. Retrovirally expressed Cdc34 and Cdc34DN were epitope tagged with Flag and they migrate slower on the gel. The levels of recombinant Cdc34 and Cdc34DN are at least fivefold higher than the endogenous Cdc34 when we probe the membrane with an anti-Cdc34 antibody that recognizes both recombinant and endogenous Cdc34 (Figure 6b ). These cell lines were synchronized by contact inhibition as described in Figure 1 . Cells were allowed to enter the cell cycle after splitting in the growth media and were collected at the indicated times. The steady-state levels of Ski were determined by Western blot analysis. As shown in Figure 6b , the level of Ski was low during G1 or S phases of the cell cycle in cells expressing HA-Ski and wild-type Cdc34, which is very similar to what we observed in Figure 1 . In contrast, the levels of Ski remain constant throughout the cell cycle in cells expressing the dominant-negative Cdc34. These results indicate that cell cycle-dependent Ski degradation is regulated by Cdc34.
Ski and dominant-negative Cdc34 synergistically antagonize TGF-b signaling
Previous studies demonstrated that overexpression of Ski inhibits TGF-b signaling and enables cells to escape TGF-b growth inhibition partially (Akiyoshi et al., 1999; Luo et al., 1999; Sun et al., 1999a; Xu et al., 2000) . If Cdc34 regulates Ski degradation, changes in the Ski degradation pattern should affect TGF-b signaling. To test this hypothesis, we measured TGF-b responsiveness in mink lung cells stably expressing Ski and Cdc34. Recombinant retroviruses expressing Ski or Cdc34 were used to infect PE25 cells and stable cell lines were created using FACS sorting. In cells expressing Ski, we only observe a less than threefold increase in luciferase activity upon TGF-b treatment for 24 h (Figure 7 ). Stable expression of the wild-type Cdc34 in PE25 mink lung cells enhanced the TGF-b response by more than twofold, while stable expression of the dominant negative did not affect TGF-b transcriptional responses in these cells. Since mink lung cells do not express endogenous Ski, it is likely that modulation of the reporter gene expression by Cdc34 could be a result of enhanced degradation of a general repressor protein that controls the basal level of this reporter gene. The reason we did not observe any significant effect of dominant-negative Cdc34 could be due to insufficient levels of the expression of dominant-negative mutants. Importantly, stable expression of Cdc34 in Ski-expres- 35 S-labeled Ski was added to Xenopus interphase extracts in the presence of anti-Cdc34 or control antibodies. Aliquots were removed at the indicated times and resolved by SDS-PAGE. Lanes 1-3, Ski control; lanes 4-6, monoclonal antibody Cdc34 at 80 ng/ml; lanes 7-12, affinity purified His 6 -Cdc34 from Escherichia coli was added to the interphase extracts at 0.2 mM (lanes 7-9) or 2 mM (lanes 10-12) after preincubation with anti-Cdc34 antibody. (c) The amounts of Ski remaining in the interphase extracts in (b). Results are mean þ s.e. of two representative experiments. (d) Coomassie Blue staining of the recombinant His 6 -Cdc34 and His 6 -HDAC4 that were used in the add-back experiment. (e) Addition of a control antibody does not inhibit Ski degradation and affinity purified His 6 -HDAC4 (1 mM) does not negate the effect of the antiCdc34 antibody on Ski degradation. Lanes 1-3, mouse preimmune antisera added at 80 ng/ml. Affinity purified His 6 -HDAC4 was added to the reaction at 1 mM in the presence (lanes 4-6) or absence (lanes 7-9) of the anti-Cdc34 antibody. (f) Degradation of Ski in the presence of a control antibody. Results are mean þ s.e. of two representative experiments limit its activity by controlling its degradation. Taken together, these data suggest Ski and Cdc34 functionally antagonize each other and support the notion that Cdc34 is the E2 enzyme that regulates the degradation of Ski.
Discussion
Overexpression of Ski proto-oncoprotein can cause cellular transformation and disruption of one of the major signaling pathways by which TGF-b inhibits cell proliferation. Tight control of Ski expression is necessary to maintain the normal response to TGF-b. Here, we have demonstrated that Ski is an unstable protein and that the steady-state levels of Ski are regulated in a cell cycle-dependent manner in cultured cells and in a cell-free degradation system. We have also shown that a Cdc34-dependent protein degradation pathway is involved in controlling the steady levels of Ski. This controlling mechanism is likely to be important for limiting the activity of this proto-oncoprotein and regulating cellular response to TGF-b. Ski and SnoN share more than 67% sequence identity in their N-terminal domains and the metabolic stability of both proteins is regulated by cell cycle progression and TGF-b signaling; however, there are substantial differences in how their stabilities are regulated. First of all, in the cell-free degradation system, degradation of SnoN occurs only in mitosis in a D-box dependent manner; no significant destabilization of SnoN was observed in interphase extracts (Wan et al., 2001) . In contrast, degradation of Ski mainly occurs in interphase extracts independent of the presence of the D-box. Therefore, a different type of degradation signal is likely required for Ski degradation. Our preliminary data suggest that a carboxyl-terminal domain of Ski is required for cell cycle-dependent regulation (Macdonald and Liu, unpublished observation) . Interestingly, the carboxyl-terminal region of Ski and SnoN are quite divergent. Further experiments are necessary to pinpoint the exact degradation signal. We suspect that the presence of a specific degradation signal(s) in Ski but not in SnoN is responsible for differences in their degradation patterns in cell extracts and biological activities in vivo. Second, destabilization of Ski is kinetically different from SnoN in response to TGF-b signaling. Degradation of Ski is much slower and depends on the concentration of TGF-b in vivo. In the case of TGF-b-induced SnoN degradation, Wrana and co-workers have shown that degradation of SnoN can be mediated by the HECT domain ubiquitin protein ligase Smurf2 . Recently, we and others have demonstrated that both cell cycle regulated and TGF-b-stimulated SnoN degradation occur through an APC-dependent, proteasome-mediated mechanism and requires the intact D-box motif at the Nterminus of SnoN Wan et al., 2001) . Such a mechanism is unlikely to account for the destabilization of Ski in response TGF-b treatment as the D-box in Ski is not required for Ski degradation. It would be interesting to test whether Smurf2 or other ubiquitin E3 enzymes are involved in Ski degradation.
c-Ski transcripts are ubiquitously expressed in many tissues and are present during embryogenesis. Several studies indicated that c-Ski mRNA levels are relatively constant during the cell cycle, myogenic differentiation and embryogenesis (Grimes et al., 1993; Ambrose et al., 1995) . The present study suggests that regulated proteolysis of Ski is one of the important ways to control its activity. Consistent with this hypothesis was the finding that Ski is an unstable protein with a half-life of less than 2 h in vivo (Sutrave et al., 1990a; Sun et al., 1999b) . Our in vitro and in vivo studies strongly indicate that a Cdc34-mediated protein degradation pathway is involved in Ski degradation. Cdc34 was originally identified as an essential regulator for ubiquitinmediated degradation of a G1 Cdk inhibitor. Cdc34 promotes the cell cycle transition from G1 to S in budding yeast. The human homolog of Cdc34 can complement the yeast cdc34-2 temperature-sensitive strain (Plon et al., 1993) . Recently, studies in vertebrate systems suggest that Cdc34-regulated proteolysis is required for the onset of DNA replication (Yew and Kirschner, 1997; Michael and Newport, 1998) . Only Wee1, Xic 1 and hICERII-g have been identified as specific targets of Cdc34 in vertebrate system ATF5 (Yew and Kirschner, 1997; Michael and Newport, 1998; Pati et al., 1999) . Identification of Ski as a target for Cdc34 suggests that Cdc34 may also function to regulate the cellular response to growth factors and to control cell cycle progression in mammalian cells.
What is the physiological relevance of the regulated proteolysis of Ski? One obvious purpose of this regulation is to maintain the proper level of Ski expression in certain cell types so that it will not interdict TGF-b signaling. Expression of Cdc34 is regulated during development and cell differentiation (Plon et al., 1993) . It is therefore conceivable that the levels of Ski expression will vary considerably during development and cell differentiation. This may contribute to differential cellular responses to TGF-b. Ski has been shown to bind N-CoR and mSin3A and recruit HDAC to repress the transcription of many cellular genes (Akiyoshi et al., 1999; Nomura et al., 1999) . In this regard, we speculate that variations in Ski levels may contribute to cell cycle-dependent gene expression. An alternative possibility for the regulation of Ski by Cdc34 could be that ubiquitination of Ski may have a direct impact on its ability to regulate transcription. Recent evidence suggests that post-translational modifications of transcriptional activators and repressors by ubiquitin-like molecules are important for transcriptional activation and repression (Jin and Harper, 2003) . In the case of the c-myc transcription factor, ubiquitination is required for c-myc to activate its targets (Kim et al., 2003; von der Lehr et al., 2003) . It is possible that ubiquitination of transcription factors increases the dynamic exchange of molecular machinery near a given promoter. Future experiments would be necessary to test whether this is the case for c-Ski.
Materials and methods

Cell lines, transfection and infection
Mv1Lu mink lung epithelial cells, PE25, HeLa S3, BOSC23 and 293T cell lines were maintained in the DMEM medium supplemented with L-glutamine, penicillin, streptomycin and 10% fetal bovine serum (GIBCO/BRL). 293T cells were transfected using FuGene 6 (Roche). Retroviral infection and cell sorting were performed as described previously (Liu et al., 1997) .
DNA expression constructs and luciferase assay
Construction of pEXL-HA-Ski has been described (Sun et al., 1999a) . HA-Ski was cloned into a retroviral vector pMX-IRES-mCD2. Ski deletion mutants were constructed using a QuikChange Mutagenesis Kit (Stratagene). pSG5 vector, pSG5-Cdc34 and pSG5-Cdc34DN were kindly provided by Dr Plon. Retroviral expression vectors pMX-Cdc34-IRES-GFP and pMX-Cdc34DN-IRES-GFP were constructed by inserting Cdc34 and Cdc34DN into the polylinker region of pMX-IRES-GFP (Liu et al., 1997) . Luciferase reporter gene assays were performed as described previously (Liu et al., 1997) .
Cell synchronization and cell cycle analysis
HeLa cells were synchronized by double thymidine arrest (2 mM) and released at varying times into the culturing medium. Cells were stained with propidium iodide and analysed by FACScan (BD system). Mink lung cells were synchronized by density arrest and released into the fresh DMEM medium after being split as described previously (Laiho et al., 1990) .
Antibodies and Western blot analysis
Protein extracts were obtained from cell lines by lysing equal numbers of cells directly in cell lysis buffer (50 mM Tris-HCl, pH 7.4, 200 mM NaCl, 1 mM EDTA, 1% NP40, 15% glycerol). Samples were resolved by 8 or 12% SDS-PAGE and electrophoretically transferred to nitrocellulose. Western blot analysis was performed using the HA1.1 monoclonal antibody (Covance), anti-v-Ski (Cascade Bioscience), anti-a-tubulin (ICN) anti-Cdc34 (Transduction Laboratories) and HRPconjugated goat-anti-mouse or anti-rabbit secondary antibody (Amersham) with a WestDura ECL detection kit (Pierce). The data were scanned by densitometry and quantified using the Image J program.
Recombinant proteins
Both wild-type and dominant-negative human Cdc34 were subcloned into the pQE30 expression vector and recombinant proteins were purified over Ni-nitrilotriacetic acid resin (Qiagen). The protein eluates were further purified using a Superdex 200 gel filtration column (Amersham Biosciences). The fractions corresponding to Cdc34 dimers were collected and stored in QA buffer (20 mM Tris-HCl pH 7.7, 100 mM KCl, 0.1 mM CaCl 2 1 mM MgCl 2 and 1 mM DTT) plus 10% glycerol. Recombinant wild-type and dominant-negative Ubc5 and Ubc10 were cloned into the pQE30 expression vector and recombinant proteins were prepared as described above.
Protein degradation assay
Both interphase and mitotic cell extracts from Xenopus eggs were prepared as described previously (Murray, 1991) .
35 Slabeled HA-tagged human Ski and SnoN or Ski mutant proteins were synthesized by the TNT reticulocyte lysate system (Promega). Reaction mixtures containing 10 ng of 35 Slabeled protein, 1.25 mg/ml ubiquitin (Sigma), 0.1 mg/ml cycloheximide and an energy regeneration system were incubated at room temperature. Aliquots were removed at indicated time points and reactions were terminated by the addition of SDS sample buffer. Samples were analysed by 8% SDS-PAGE. Degradation of Ski was determined by quantitation of Ski protein through PhosphorImaging analysis or autoradiography.
